These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

786 related items for PubMed ID: 17335562

  • 1. Diagnostic and prognostic accuracy of clinical and laboratory parameters in community-acquired pneumonia.
    Müller B, Harbarth S, Stolz D, Bingisser R, Mueller C, Leuppi J, Nusbaumer C, Tamm M, Christ-Crain M.
    BMC Infect Dis; 2007 Mar 02; 7():10. PubMed ID: 17335562
    [Abstract] [Full Text] [Related]

  • 2. Procalcitonin predicts patients at low risk of death from community-acquired pneumonia across all CRB-65 classes.
    Krüger S, Ewig S, Marre R, Papassotiriou J, Richter K, von Baum H, Suttorp N, Welte T, CAPNETZ Study Group.
    Eur Respir J; 2008 Feb 02; 31(2):349-55. PubMed ID: 17959641
    [Abstract] [Full Text] [Related]

  • 3. Utility of procalcitonin, C-reactive protein and white blood cells alone and in combination for the prediction of clinical outcomes in community-acquired pneumonia.
    Zhydkov A, Christ-Crain M, Thomann R, Hoess C, Henzen C, Werner Z, Mueller B, Schuetz P, ProHOSP Study Group.
    Clin Chem Lab Med; 2015 Mar 02; 53(4):559-66. PubMed ID: 25014522
    [Abstract] [Full Text] [Related]

  • 4. Utility of two biomarkers for directing care among patients with non-severe community-acquired pneumonia.
    España PP, Capelastegui A, Bilbao A, Diez R, Izquierdo F, Lopez de Goicoetxea MJ, Gamazo J, Medel F, Salgado J, Gorostiaga I, Quintana JM, Population Study of Pneumonia (PSoP) Group.
    Eur J Clin Microbiol Infect Dis; 2012 Dec 02; 31(12):3397-405. PubMed ID: 23010902
    [Abstract] [Full Text] [Related]

  • 5. Circulating levels of pro-atrial natriuretic peptide in lower respiratory tract infections.
    Müller B, Süess E, Schuetz P, Müller C, Bingisser R, Bergmann A, Stolz D, Tamm M, Morgenthaler NG, Christ-Crain M.
    J Intern Med; 2006 Dec 02; 260(6):568-76. PubMed ID: 17116008
    [Abstract] [Full Text] [Related]

  • 6. The utility of biomarkers in differentiating bacterial from non-bacterial lower respiratory tract infection in hospitalized children: difference of the diagnostic performance between acute pneumonia and bronchitis.
    Hoshina T, Nanishi E, Kanno S, Nishio H, Kusuhara K, Hara T.
    J Infect Chemother; 2014 Oct 02; 20(10):616-20. PubMed ID: 25027057
    [Abstract] [Full Text] [Related]

  • 7. Diagnostic accuracy of C-reactive protein and procalcitonin in suspected community-acquired pneumonia adults visiting emergency department and having a systematic thoracic CT scan.
    Le Bel J, Hausfater P, Chenevier-Gobeaux C, Blanc FX, Benjoar M, Ficko C, Ray P, Choquet C, Duval X, Claessens YE, ESCAPED study group.
    Crit Care; 2015 Oct 16; 19():366. PubMed ID: 26472401
    [Abstract] [Full Text] [Related]

  • 8. The value of procalcitonin level in community-acquired pneumonia in the ED.
    Park JH, Wee JH, Choi SP, Oh SH.
    Am J Emerg Med; 2012 Sep 16; 30(7):1248-54. PubMed ID: 22030193
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Predictive values of semi-quantitative procalcitonin test and common biomarkers for the clinical outcomes of community-acquired pneumonia.
    Ugajin M, Yamaki K, Hirasawa N, Yagi T.
    Respir Care; 2014 Apr 16; 59(4):564-73. PubMed ID: 24170911
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Performance of pro-adrenomedullin for identifying adverse outcomes in community-acquired pneumonia.
    España PP, Capelastegui A, Mar C, Bilbao A, Quintana JM, Diez R, Esteban C, Bereciartua E, Unanue U, Uranga A.
    J Infect; 2015 May 16; 70(5):457-66. PubMed ID: 25499199
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Usefulness of a semi-quantitative procalcitonin test and the A-DROP Japanese prognostic scale for predicting mortality among adults hospitalized with community-acquired pneumonia.
    Kasamatsu Y, Yamaguchi T, Kawaguchi T, Tanaka N, Oka H, Nakamura T, Yamagami K, Yoshioka K, Imanishi M.
    Respirology; 2012 Feb 16; 17(2):330-6. PubMed ID: 22059525
    [Abstract] [Full Text] [Related]

  • 17. Use of plasma C-reactive protein, procalcitonin, neutrophils, macrophage migration inhibitory factor, soluble urokinase-type plasminogen activator receptor, and soluble triggering receptor expressed on myeloid cells-1 in combination to diagnose infections: a prospective study.
    Kofoed K, Andersen O, Kronborg G, Tvede M, Petersen J, Eugen-Olsen J, Larsen K.
    Crit Care; 2007 Feb 16; 11(2):R38. PubMed ID: 17362525
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Utility of serum procalcitonin and C-reactive protein in severity assessment of community-acquired pneumonia in children.
    Agnello L, Bellia C, Di Gangi M, Lo Sasso B, Calvaruso L, Bivona G, Scazzone C, Dones P, Ciaccio M.
    Clin Biochem; 2016 Jan 16; 49(1-2):47-50. PubMed ID: 26386341
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 40.